What is the treatment for an olanzapine (atypical antipsychotic) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Olanzapine Overdose

The primary treatment for olanzapine overdose includes activated charcoal administration (if within 1-6 hours of ingestion), supportive care with airway management, and monitoring for complications such as CNS depression, anticholinergic toxicity, and metabolic disturbances. 1, 2

Initial Assessment and Stabilization

  • Assess and secure airway, breathing, and circulation as olanzapine overdose commonly causes CNS depression that may require intubation and mechanical ventilation 2, 3
  • Monitor vital signs with particular attention to heart rate (tachycardia is common), blood pressure (hypotension may occur), respiratory rate, and temperature 4
  • Obtain baseline laboratory studies including complete blood count, comprehensive metabolic panel, creatine phosphokinase, and blood glucose (hyperglycemia is a common finding) 4, 3
  • Consider ECG monitoring for QTc prolongation, though this is less common than with other antipsychotics 4, 5

Specific Interventions

Gastrointestinal Decontamination

  • Administer activated charcoal (1 g/kg) if the patient presents within 1-6 hours of ingestion and has a protected airway 1
  • Activated charcoal reduces the Cmax and AUC of oral olanzapine by approximately 60%, making it particularly effective for olanzapine overdose 1
  • Multiple-dose activated charcoal is not recommended as olanzapine does not undergo significant enterohepatic recirculation 1

Management of Anticholinergic Toxicity

  • Monitor for and treat anticholinergic symptoms including tachycardia, hyperthermia, dry mucous membranes, urinary retention, and delirium 2
  • Benzodiazepines (lorazepam 0.5-2 mg IV every 6 hours) may be used to manage agitation and delirium 6
  • Physostigmine is generally not recommended for olanzapine-induced anticholinergic toxicity due to risk of seizures and cardiac arrhythmias 4

Management of CNS Depression

  • Position patient to protect airway; intubation may be necessary in severe cases 7, 3
  • Avoid medications that may further depress the CNS 1
  • For patients with cerebral edema (rare complication), consider mannitol administration and neurosurgical consultation 2

Management of Metabolic Disturbances

  • Monitor blood glucose frequently and treat hyperglycemia with insulin if needed 4, 3
  • Monitor for metabolic acidosis and correct electrolyte abnormalities 4
  • Monitor creatine phosphokinase for evidence of rhabdomyolysis 4, 5

Monitoring and Supportive Care

  • Continuous cardiac monitoring for at least 24 hours in symptomatic patients 5
  • Monitor for extrapyramidal symptoms which may appear 24-72 hours after ingestion 7, 5
  • Provide IV fluids to maintain adequate hydration and blood pressure 4, 3
  • Monitor for seizures, which although rare, may occur in severe overdoses 2, 7

Special Considerations

  • Avoid medications with anticholinergic properties as they may worsen anticholinergic toxicity 1
  • Use caution with benzodiazepines as co-administration may increase somnolence 1
  • Avoid dopamine antagonists (metoclopramide, phenothiazines, haloperidol) to prevent excessive dopamine blockade 6
  • No specific antidote exists for olanzapine overdose; treatment is primarily supportive 3

Prognosis and Disposition

  • Most patients with olanzapine overdose recover fully with supportive care 7, 3
  • Admission to an intensive care unit is recommended for patients with significant symptoms 4, 5
  • Psychiatric evaluation should be considered prior to discharge for intentional overdoses 7
  • Even very high doses (up to 400 mg in adolescents and 180 mg in young children) have been survived with appropriate supportive care 7, 3

Breakthrough Treatment for Olanzapine-Induced Nausea/Vomiting

For patients taking therapeutic doses of olanzapine who experience breakthrough nausea/vomiting:

  • Consider alternative antiemetics such as 5-HT3 antagonists (ondansetron), benzodiazepines (lorazepam), or dexamethasone 6
  • Avoid other dopamine antagonists when possible to prevent excessive dopamine blockade 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.